| Date | Title | Description |
| 24.10.2024 | The Future of Drug Discovery: Dotmatics' Geneious Luma Takes Center Stage | In the world of drug discovery, time is money. The race to develop new therapies is a marathon, not a sprint. Yet, with the launch of Geneious Luma by Dotmatics, the landscape is shifting. This innovative platform aims to cut through the no... |
| 22.10.2024 | Dotmatics aims to speed drug development, break data silos with Geneious Luma | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Even as enterprises across sectors explore how to integrate generative AI, it’s clear that biomedical research an... |
| 22.08.2024 | Women Leading the Charge in Business Innovation | In the bustling heart of the Bay Area, a revolution is brewing. Women are stepping into the spotlight, reshaping industries and driving innovation. The recent recognition of Dr. Jo Varshney and Melanie Margolin exemplifies this shift. Their... |
| 21.08.2024 | Dr. Jo Varshney Named to List of Most Influential Women in Bay Area Business from the San Francisco Business Times | Dr. Jo Varshney of VeriSIM Life recognized as one of the most prominent and powerful female bay area business leaders in 2024.
VeriSIM Life Founder and CEO Awarded as one of the Most Prominent and Powerful Female Bay Area Business Leaders i... |
| 26.07.2024 | The AI Revolution: Transforming Search Engines and Pharmaceutical Research | In the digital age, two industries are undergoing seismic shifts: search engines and pharmaceutical research. Both are harnessing the power of artificial intelligence (AI) to redefine their landscapes. The competition is fierce, and the sta... |
| 22.07.2024 | Can AI increase the pace and quality of pharmaceutical research? VeriSIM Life says yes | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
We’ve already seen how AI can be used to help uncover the structure of proteins and discover new materials, so it... |
| 15.05.2024 | Accelerating Clinical Translation of Antibody-Drug Conjugates with Hybrid AI, Upcoming Webinar Hosted by Xtalks | www.verisimlife.com
In this free webinar, gain insights into real-world applications of artificial intelligence (AI) in preclinical cancer drug research. Attendees will learn best practices for implementing a hybrid AI approach to drug desi... |
| 03.04.2024 | VeriSIM Life Announces the Launch of AtlasGEN™ Novel Drug Designer | VeriSIM Life announced the availability of AtlasGEN™ Novel Drug Designer, the first and only platform to design clinical success into the discovery of new drugs from day one.
Pharmaceutical industry's first platform to design clinical succe... |
| 10.08.2023 | Using AI in Drug Development to Enhance Preclinical Translatability, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars Integrating computational models and drug intelligence datasets at different R&D stages, along with adding machine learning (ML) to understand those interactions enables better predictions and identifies pot... |
| 26.04.2023 | VeriSIM Life Partners with Clarivate to Help Researchers Accelerate and De-Risk Drug Development | Partnership will improve pre-clinical success rates by leveraging VeriSIM's AI drug decision engine and R&D drug discovery intelligence platform from Clarivate
SAN FRANCISCO, April 26, 2023 /PRNewswire/ -- VeriSIM Life (VeriSIM) www.ver... |
| 14.12.2022 | How Taking Smart Risks Makes Drug Development Less Speculative | Dr. Jo Varshney, founder and CEO of VeriSIM Life. |
| 13.12.2022 | VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best Practices in AI-enabled Preclinical Development Industry | VeriSIM Life eliminates waste and inaccuracy, accelerates preclinical development, and lowers costs and risks when converting drug candidates to clinical trials, and brings life-saving drugs to market faster.
SAN ANTONIO, Dec. 13, 2022 /PRN... |
| 04.11.2022 | VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough | VeriSIM Life (VeriSIM), the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, announced it has been selected as the winner of the “Predictive Analytics Solution of the Year” ... |
| 07.01.2022 | VeriSIM Life Secures $15 Million Series A Funding | Financing led by Morpheus Ventures supports further revenue growth for the company’s next-generation AI platform, redefining the preclinical translational medical drug development landscape by accurately predicting and accelerating clinical... |
| 06.01.2022 | VeriSIM Life Completes $15M Series A Financing |
SAN FRANCISCO, CA, VeriSIM Life, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, has closed its oversubscribed $15 million Series A round.
>> Click here for mo... |
| 06.01.2022 | VeriSIM Life Secures $15 Million Series A Funding | VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round.... |
| 06.01.2022 | VeriSIM Life Raises $15M in Series A Funding | VeriSIM Life, a San Francisco, CA-based artificial intelligence (AI)-enabled, R&D decisions de-risker for breakthrough drug development, closed its $15 million Series A funding round.
The round was led by Morpheus Ventures with particip... |
| 26.07.2021 | PulmoSIM Therapeutics Announces Strategic Partnership with Top Respiratory Hospitals to Initiate Clinical Development of PT001 to Treat Pulmonary Arterial Hypertension | All the sessions from Transform 2021 are available on-demand now. Watch now.
After receiving orphan drug designation, PulmoSIM in partnership with National Jewish Health (#1 Respiratory Hospital) and Brown University, seeks to develop the f... |
| 26.07.2021 | PulmoSIM Therapeutics Announces Strategic Partnership with Top Respiratory Hospitals to Initiate Clinical Development of PT001 to Treat Pulmonary Arterial Hypertension | After receiving orphan drug designation, PulmoSIM in partnership with National Jewish Health (#1 Respiratory Hospital) and Brown University, seeks to develop the first curative treatment for PAH.
SAN FRANCISCO–(BUSINESS WIRE)–July 26, 2021–... |
| 22.03.2021 | VeriSIM Life launches PulmoSIM Therapeutics to Develop Treatments for Rare Respiratory Diseases | SAN FRANCISCO–(BUSINESS WIRE)–March 22, 2021–
Today, VeriSIM Life (VeriSIM) announces the launch of its pharmaceutical subsidiary, PulmoSIM Therapeutics (PulmoSIM) with the mission to address the unmet needs in the treatment of rare respira... |
| 22.03.2021 | VeriSIM Life launches PulmoSIM Therapeutics to Develop Treatments for Rare Respiratory Diseases | SAN FRANCISCO--(BUSINESS WIRE)--Mar 22, 2021--
Today, VeriSIM Life (VeriSIM) announces the launch of its pharmaceutical subsidiary, PulmoSIM Therapeutics (PulmoSIM) with the mission to address the unmet needs in the treatment of rare respir... |
| 02.03.2021 | VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19 | SAN FRANCISCO--(BUSINESS WIRE)--Mar 2, 2021--
VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to conduct research and development (R&D) work on rapid repurpo... |
| 25.08.2019 | VeriSIM Life Secures $5.2 Million To Prevent Unnecessary Drug Testing In Animals | VeriSIM Life recently announced that it raised $5.2 million in a seed series co-led by several investors
Dr. Jo Varshney — a celebrated leader in veterinary and human health development — and a group of world-class scientists and engineers ... |
| 19.08.2019 | Top tech startup news for today, Monday, August 19, 2019 | Below are some of the top tech startup news for today, Monday, August 19, 2019.
Disney streaming service is set to launch on all the major streaming platforms except Amazon. The much-anticipated Disney streaming service, Disney+, will laun... |
| 15.08.2019 | Daily funding roundup - August 15th, 2019 | Miko raised $7.5M; Commsignia closed $11M; FlyHomes landed $21M; Nurx secured $32M
Fitz Frames: Fitz Frames is solving glasses for kids and parents because those who can see the world are the ones who will change it. Fitz Frames has raised ... |
| 14.08.2019 | VeriSIM Life Raises $5.2M Round of Funding |
SAN FRANCISCO, CA, VeriSIM Life has raised $5.2M from lead investors such as Susa Ventures, Intel Capital and OCA.
>> Click here for more funding data on VeriSIM Life
>> To export VeriSIM Life funding data to PDF and Excel, ... |
| 14.08.2019 | Verisim Life uses AI-powered biosimulations to replace animal drug testing | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The global drug discovery market is estimated to ... |
| 14.08.2019 | Verisim Life uses AI-powered biosimulations to replace animal drug testing | The global drug discovery market is estimated to be worth at least $35 billion, a figure that could rise to $71 billion by 2025. But taking a drug from research and development to market is a long and resource-intensive process.
A large par... |
| 14.08.2019 | VeriSIM Life Raises $5.2M in Funding | VeriSIM Life, a San Francisco, CA-based company that is building digital animal and human simulations to avoid unnecessary drug testing in animals, raised $5.2M in funding.
The round was co-led by OCA Ventures and Serra Ventures with partic... |
| 02.11.2018 | Village Global’s accelerator introduces founders to Bill Gates, Reid Hoffman, Eric Schmidt and more | Village Global is leveraging its network of tech luminaries to support the next generation of entrepreneurs.
The $100 million early-stage venture capital firm, which counts as limited partners (LPs) Microsoft’s Bill Gates, Facebook’s Mark Z... |
| - | VeriSIM Life Raises $15 Million In Series A | VeriSIM Life recently announced it raised $15 million in Series A funding. These are the details.
VeriSIM Life — the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development — recent... |
